SPOTLIGHT – Talk Bio

Actionable Insights Powered by AI

Jasper Therapeutics Escalates Dose in Hives Trial Following Rapid Complete Responses

Jasper Therapeutics, briquilimab, chronic inducible urticaria, hives, dose escalation, clinical trial, SPOTLIGHT study